Explore more topics
SEC Form 4 research

Opus Genetics, Inc. insider transactions

Inspect Opus Genetics, Inc.'s public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001228627
Reporting owners
44
Officers and directors
30
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Read one actual disclosure before using it

Show the table · 1 row, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-10-022026-09-30Foundation Fighting Blindness Retinal Degeneration Fund, Foundation Fighting Blindness, Inc.S556,000$4.96Not reported

First displayed source row from Recent insider disclosures. The full bounded history and coverage notes remain below.

The displayed observation date is 2026-09-30 and its public availability date is 2026-10-02. Subtracting those calendar dates gives 2 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.

This row is code S: a sale. A purchase-following rule excludes this sale even if the reported dollar amount is large.

Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 6 rows, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-10-022026-09-30Foundation Fighting Blindness Retinal Degeneration Fund, Foundation Fighting Blindness, Inc.S556,000$4.96Not reported
2026-09-082026-09-03Gagnon Robert E.S28,000$4.54Not reported
2026-07-282026-07-23YERXA BENJAMIN RS7,429$2.97Not reported
2026-07-282026-07-23SCHACHLE JOSEPH KS4,644$2.94Not reported
2026-07-282026-07-23Magrath GeorgeS9,475$2.95Not reported
2026-07-282026-07-23Gagnon Robert E.S7,783$2.95Not reported

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Inspect all 30 displayed rows: Officers and directors in the directory

Scroll sideways to compare all columns. Select a heading to sort.

YERXA BENJAMIN R000114591090
Sooch Mina00016740064
Gallagher Cam0001557832134
MANUSO JAMES S J00012363659
Ainsworth Sean00018302961
Benton Susan00013736491
Pepose Jay00018661912
Swirsky Douglas J000137588425
Rodgers Richard J00013133971
Brandt Peter C.000143409940
Ahn Chang Ho000131642014
Beever Charles000136168710
Cheong Kwang Soo00013616861
Foundation Fighting Blindness Retinal Degeneration Fund00020422663
Foundation Fighting Blindness, Inc.00020425323
Gagnon Robert E.000150498373
Hoffman Freddie Ann00014023951
Jayagopal Ashwath00020089833
Jeong Tae Heum00013171906
Jhaveri Nirav S.00020114811
Kang Y Michele00013616859
Kivel Richard00015037571
Magrath George00019993908
McIntosh David M00013172482
MEYER ALAN R00012121621
Nolan Lisa00016614001
Park Young Soon00013164221
Price Ben Gil000141791511
SCHACHLE JOSEPH K00011459144
Zaremba Rabourn Amy00018323432

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.